
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
[ Tue, Dec 19th 2023 ]: WOPRAI
Mani Foroohar Upgraded (WVE) to Buy and Held Target at $12 on, Dec 19th, 2023


🞛 This publication is a summary or evaluation of another publication
Mani Foroohar of Leerink Partners, Upgraded "Wave Life Sciences Ltd." (WVE) to Buy and Held Target at $12 on, Dec 19th, 2023.
Mani, nor any peers, have made any analyst calls on WVE in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30